Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
A one-shot gene-editing cholesterol therapy could soon be a reality
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
Revenue from operations climbed 13% to Rs. 886.87 crore
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.
Subscribe To Our Newsletter & Stay Updated